Ioana Bancu

Ioana Bancu

Auto-generated profile, based on publicly available information

Ioana Bancu

Current address: Department of Nephrology, Hospital Universitari Germans Trias i Pujol, Crta. Canyet s/n, 08916, Badalona, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
AMAna Merino-Ribas
Ana Merino-Ribas
Ricardo AraujoRicardo Araujo
Ricardo Araujo
LPLuciano Pereira
Luciano Pereira
Joana CamposJoana Campos
Joana Campos
LBLuisa Barreiros
Luisa Barreiros
Benedita Sampaio-MaiaBenedita Sampaio-Maia
Benedita Sampaio-Maia
Vascular calcification (VC) is a frequent condition in chronic kidney disease (CKD) and a well-established risk factor for the development of cardiovascular disease (CVD). Gut dysbiosis may contribute to CVD and inflammation in CKD patients. Nonetheless, the role of gut and blood microbiomes in CKD-associated VC remains unknown. Therefore, this pilot study aimed to explore the link between gut and blood microbiomes and VC in CKD patients on peritoneal dialysis (CKD-PD). Our results showed relative changes in specific taxa between CKD-PD patients with and without VC, namely Coprobacter, Coprococcus 3, Lactobacillus, and Eubacterium eligens group in the gut, and Cutibacterium, Pajaroellobacter, Devosia, Hyphomicrobium, and Pelomonas in the blood. An association between VC and all-cause mortality risk in CKD-PD patients was also observed, and patients with higher mortality risk corroborate the changes of Eubacterium eligens in the gut and Devosia genus in the blood. Although we did not find differences in uremic toxins, intestinal translocation markers, and inflammatory parameters among CKD-PD patients with and without VC, soluble CD14 (sCD14), a nonspecific marker of monocyte activation, positively correlated with VC severity. Therefore, gut Eubacterium eligens group, blood Devosia, and circulating sCD14 should be further explored as biomarkers for VC, CVD, and mortality risk in CKD.

28 September 2017 in Journal of Aging Research
Verified
Journal Article
Open access
PDF file
IBIoana Bancu
Ioana Bancu
FGFredzzia Graterol
Fredzzia Graterol
JBJorge Bonal
Jorge Bonal
PFPilar Fernández-Crespo
Pilar Fernández-Crespo
JGJessica Garcia
Jessica Garcia
JBJosep Bonet
Josep Bonet
Introduction. Labeling a patient as “frail” may be useful in assessing the prognosis and therapeutic approach. Objective. The aim of the study is to define a pattern of frailty among our dialysis population, to analyse the incidence and clinical evolution of these patients. Materials and Methods. We analysed a total of 320 patients with stage V chronic kidney disease (CKD) who were on hemodialysis between September 2014 and September 2015. To define a patient as frail we used the Fried phenotype model, and we added a new criteria-dialysis session length longer than 12 hours/week. Results. 5.6% of the 320 patients were frail. We found statistically significant differences regarding body mass index (BMI), hemoglobin (Hgb), and serum albumin, as well as the ability to perform the basic activities of daily living (p<0.005), ability to ambulate (p=0.01) and perform transfers (p<0.005). We found statistically significant differences between the two groups in terms of hospital admissions (p=0.005) and mortality (p<0.005). Conclusion. 5.6% of the study population were frail, with lower BMI, serum albumin and hemoglobin, lower capacity for basic activities of daily living, ambulation, and transference, as well as higher morbidity and mortality.

3 May 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
IBIoana Bancu
Ioana Bancu
MDMaruja Navarro Díaz
Maruja Navarro Díaz
ASAssumpta Serra
Assumpta Serra
MGMarisa Granada
Marisa Granada
DLDolores Lopez
Dolores Lopez
JBJosep Bonet
Josep Bonet
IGF-1 (insulin-like growth factor-1) is a hormone involved in cell growth and other important processes. In the kidney, IGF-1 has a stimulating effect, increasing the blood flow and glomerular filtration rate. Although many experimental animal studies regarding the role of IGF-1 in the kidney have been conducted, few human studies are available in the literature. Obesity is a cause of renal failure, and several glomerular lesions associated with obesity have been described. However, no studies regarding the levels of IGF-1 in morbidly obese patients with renal injury associated with obesity have been conducted. To determine the serum IGF-1 concentrations in morbidly obese patients with normal renal function but with different types of early obesity-related glomerular lesions and to evaluate the possible relationship between IGF-1 and the presence of renal lesions. Eighty morbidly obese patients with renal biopsy, including 11 patients with no evidence of renal lesion, 17 patients with single glomerulomegaly, 21 patients with single podocyte hypertrophy, 10 patients with glomerulomegaly and podocyte hypertrophy, 5 patients with focal segmental hyalinosis, and 16 patients with increased mesangial matrix and/or mesangial proliferation, participated in this study. Biological parameters, including serum IGF-1 concentrations with the standard deviation score for age (SDS-IGF-1), were determined for all patients. Eighty patients (50 women and 30 men) with a mean BMI of 52.63 ± 8.71 and a mean age of 42.40 ± 9.45 years were included in this study. IGF-1, IGF-1 SDS and IGF-1BP3 levels according to the renal injury were compared (normal glomeruli: IGF-1 = 190.17 ± 72.46; glomerulomegaly: IGF-1 = 122.3 ± 50.05; podocyte hypertrophy: IGF-1 = 119.81 ± 60.34; focal segmental hyalinosis: IGF-1 170.98 ± 100.83, increased mesangial matrix and/or mesangial proliferation: IGF-1 117.73 ± 63.87). Statistically significant differences were observed between serum levels of IGF-1 and between the levels of SDS-IGF-1 by comparing the group without glomerular lesion with the group formed by patients with any type of glomerular injury. Logistic regression analysis was performed, with the dependent variable defined as the glomerular injury. In the multivariate analysis, only SDS-IGF-1 was associated with glomerular injury, and low levels of IGF-1 SDS were a risk factor for kidney injury. Our study demonstrates that low IGF-1 serum levels are associated with renal lesions in morbidly obese patients without overt clinical renal manifestations.

24 February 2021 in Clinical Research in Cardiology
Verified
Journal Article
Closed access
PDF file
FGFrancisco Gual-Capllonch
Francisco Gual-Capllonch
JLJosep Lupón
Josep Lupón
IBIoana Bancu
Ioana Bancu
FGFredzzia Graterol
Fredzzia Graterol
EFElena Ferrer-Sistach
Elena Ferrer-Sistach
ABAntoni Bayes
Antoni Bayes

1 November 2016 in Transplantation Proceedings
Verified
Journal Article
Closed access
IBI. Bancu
I. Bancu
AHA. Hernández-Gallego
A. Hernández-Gallego
DLD. López-Alvárez
D. López-Alvárez
ILI. Lozano-Ramos
I. Lozano-Ramos
LCL. Cañas-Sole
L. Cañas-Sole
RLR. Lauzurica
R. Lauzurica

1 July 2015 in Nefrología
Verified
Journal Article
Open access
AGAna Patricia González-Cáceres
Ana Patricia González-Cáceres
IBIoana Bancu
Ioana Bancu
FJFrancisco Javier Juega-Mariño
Francisco Javier Juega-Mariño
LCLaura Cañas-Solé
Laura Cañas-Solé
JBJosep Bonet
Josep Bonet
RLRicardo Lauzurica
Ricardo Lauzurica